Sanofi SA Chief Executive Chris Viehbacher tells reporters: * Expects vaccines business to return to double-digit growth in H2 * "Could imagine" U.S. launch of cholesterol drug alirocumab in H2 2015, ahead or at same time as Amgen Inc * "Everybody is talking to everybody" on what to do with mature drug portfolios
Amgen Inc. is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics. Shares of AMGN traded higher by 5.43% or $6.7/share to $130.01. In the past year, the shares have traded as low as $103.31 and as high as $131.24. On average, 2985880 shares of AMGN exchange hands on a given day and today's volume is recorded at 8472513.
Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. Shares of SNY traded higher by 1.52% or $0.78/share to $52.18. In the past year, the shares have traded as low as $46.95 and as high as $54.64. On average, 946188 shares of SNY exchange hands on a given day and today's volume is recorded at 2371333.
Source
